NCT03418038 2026-04-16Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaMayo ClinicPhase 2 Recruiting80 enrolled
NCT01959698 2026-01-28Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell LymphomaRoswell Park Cancer InstitutePhase 1 Active not recruiting29 enrolled 19 charts